Lilly needs a plan to spur weight-loss drug sales, investors say
Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
NBC Los Angeles10d
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
'It was shocking and horrific and surreal': family of Border Patrol Agent killed in Vermont speaks out
General Hospital star Laura Wright is known for being a powerhouse, but only a year ago, the Daytime Emmy-winner and soap ...
Pharmaceutical Technology14d
Solbinsiran sodium by Eli Lilly and Co for Mixed Dyslipidemia: Likelihood of Approval
Solbinsiran sodium is under clinical development by Eli Lilly and Co and currently in Phase II for Mixed Dyslipidemia. According to GlobalData, Phase II drugs for Mixed Dyslipidemia have a 74% phase ...
Jim Cramer Says ‘Eli Lilly and Company (LLY)’s Drug Is Superior In Terms Of Weight Reduction At The Same Dose’
We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are ...
The Financial Express16d
Weight loss pills Ozempic, Wegovy and Trizepatide enter Indian market
Having made waves the world over, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly’s tirzepatide are set to enter the Indian ...
Jim Cramer on Eli Lilly and Company (LLY)’s Q4 2024 Performance: ‘Aren’t As Strong As Wall Street Was Hoping’
We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks on Jim ...
The Independent20d
Oral Ozempic and a ‘miracle’ pill imitating the keto diet – a new era of weight loss is here
In 2023, Pfizer ran trials on a different oral compound, orforglipron, which belongs to the same class of medications as semaglutide, as did Eli Lilly ... of the keto diet. Based on animal ...
The Motley Fool21d
Has Eli Lilly Stock Peaked?
Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...
Investopedia21d
Watch These Eli Lilly Price Levels as Stock Slumps on Tepid Sales Outlook
Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...
STAT21d
Eli Lilly CEO on Trump, obesity drugs, and a guidance miss
What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...
Morningstar21d
Eli Lilly: Weak Preliminary Sales for Mounjaro and Zepbound; Shares Remain Overvalued
Eli Lilly announced preliminary fourth-quarter revenue of roughly $13.5 billion, or $400 million below the low end of its guidance, driven by slower-than-expected US market growth and lower ...